List, A F <br/><br/>
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Sep 1993 
 - 1652-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1993.11.9.1652  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1<br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics<br/>Carrier Proteins--genetics<br/>Child<br/>Child, Preschool<br/>Cyclosporine--adverse effects<br/>Daunorubicin--administration & dosage<br/>Drug Resistance--genetics<br/>Female<br/>Gene Expression<br/>Humans<br/>Leukemia, Myeloid--blood<br/>Male<br/>Membrane Glycoproteins--genetics<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Phenotype<br/>Survival Analysis<br/>Treatment Outcome